HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease

Angela S. Brijmohan(St. Michael's Hospital), Andrew Advani(St. Michael's Hospital)
Frontiers in Pharmacology
January 31, 2018
Cited by 65


Related Papers